Poly (ADP-Ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes

Diabetes

Volumn 52, Issue 7, 2003, Pages 1683-1688

  Suarez Pinzon, Wilma L ^a   Mabley, Jon G ^b   Power, Robert ^a   Szabó, Csaba ^b   Rabinovitch, Alex ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INOTEK CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; GAMMA INTERFERON; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHENANTHRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CELL INFILTRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DNA STRAND BREAKAGE; ENZYME INHIBITION; FEMALE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INSULITIS; LEUKOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RECURRENT DISEASE; TH1 CELL;

EID: 0038015663     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.7.1683     Document Type: Article

References (32)

1. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 46:750-757, 1997
2. Kurrer MO, Pakala SV, Hanson HL, Katz JD: β-Cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 94:213-218, 1997
3. Augustein P, Elefanty AG, Allison J, Harrison LC: Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Diabetologia 41:1381-1388, 1998
4. Raff M: Cell suicide for beginners. Nature 396:119-122, 1998
5. de Murcia G, Ménissier de Murcia J: Poly (ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 19:172-176, 1994
6. Virag L, Szabó C: The therapeutic potential of PARP inhibition. Pharmcol Rev 54:375-429, 2002
7. Lemasters JJ, Qian T, Bradham CA, Brenner DA, Casio WE, Trost LC, Nishimura Y, Nieminen AL, Herman B: Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J Bioenerg Biomembr 31:305-319, 1999
8. Hoorens A, Pipeleers D: Nicotinamide protects human beta cells against chemically-induced necrosis but not cytokine-induced apoptosis. Diabetologia 42:55-59, 1999
9. Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S: Preventative and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis: an observation in nonobese diabetic (NOD) mice. Diabetes 31:740-753, 1982
10. Garcia Soriano F, Virag L, Jagtap P, Szabó E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabó C: Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat Med 7:108-113, 2001
11. Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabó C, Endres M: Protective effects of PJ34, a novel, potent inhibitor of poly (ADP-ribose) polymerase in vitro and in vivo models of stroke. Int J Mol Med 7:255-260, 2001
12. Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabó E, Hasko G, Marton A, Lorigados CB, Gallyas F Jr, Sumegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabó C: Novel phenanthridinone inhibitors of poly (ADP-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 30:1071-1082, 2002
13. Gotoh M, Maki J, Kiyoizumi T, Satomi S, Monaco AP: An improved method for isolation of mouse pancreatic islets. Transplantation 40:437-438, 1985
14. Wang T, Singh B, Warnock G, Rajotte RV: Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 41:114-117, 1992
15. + T-cells in syngeneic islet grafts in NOD mice produce interferon-γ during β-cell destruction. Diabetes 45:1350-1357, 1996
16. Bakondi E, Bai P, Szabó E, Hunyadi J, Gergely P, Szabó C, Virag L: Detection of poly (ADP-ribose) polymerase activation in oxidatively stressed cells and tissues using biotinylated NAD substrate. J Histochem Cytochem 50:91-98, 2002
17. Rabinovitch A, Suarez-Pinzon WL, Shapiro AMJ, Rajotte RV, Power R: Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes 51:638-645, 2002
18. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter KT: Isolation of biologically, active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
19. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF: TNF-α down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. J Immunol 159:6298-6303, 1997
20. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing β-cell apoptosis. J Pathol 191:86-92, 2000
21. de Murcia G, Shall S, Eds.: From DNA Damage and Stress Signaling to Cell Death; poly ADP-Ribosylation Reactions. Oxford, U.K., Oxford University Press, 2000
22. Szabó C, Ed.: Cell Death: The Role of PARP. Boca Raton, FL, CRC Press, 2000
23. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, Kolb H: Mice lacking the poly (ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin. Nat Med 5:314-319, 1999
24. Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S, Verma A, Wang ZQ, Synder SH: Poly (ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:3059-3064, 1999
25. Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki T, Jishage K, Watanabe T, Sugimoto T, Nakagama H, Ochiya T, Sugimura T: Poly (ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:2301-2304, 1999
26. Mabley JG, Suarez-Pinzon WL, Hasko G, Salzman AL, Rabinovitch A, Kun E, Szabó C: Inhibitor of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes. Br J Pharmacol 133:909-919, 2001
27. Gonzalez C, Ménissier de Murcia J, Janiak P, Bidouard JP, Beauvais C, Karray S, Garchon HJ, Levi-Strauss M: Unexpected sensitivity of nonobese diabetic mice with a disrupted poly (ADP-ribose) polymerase-1 gene to streptozotocin-induced and spontaneous diabetes. Diabetes 51:1470-1476, 2002
28. Pozzilli P: Prevention of insulin-dependent diabetes mellitus. Diabete Metab Rev 14:69-84, 1998
29. Kolb H, Burkart V: Nicotinamide in type 1 diabetes: mechanism of action revisited. Diabetes Care 22 (Suppl. 2): B16-B20, 1999
30. Knip M, Douek IF, Moore WPT, Gilmor HA, McLean AEM, Bingley PJ, Gale EAM, for the ENDIT Group: Safety of high-dose nicotinamide: a review. Diabetologia 43:1337-1345, 2000
31. Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H, DENIS Group: the Deutsch Nicotinamide Intervention Study. Diabetes 47:980-984, 1998
32. Greenbaum CJ, Kahn SE, Palmer JP: Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM. Diabetes 45:1631-1634, 1996